As Gal-3 is considered as a biomarker for many cancers, often showing increased expression, knowledge on the molecular mechanisms by which it affects cancer cells, e.g. through Tyro3 activation as shown here, it can offer a novel avenue for cancer therapeutics and/or diagnostics. This evidence concerns the gene TYRO3 and cancer.